We are looking for children 2–17 years old to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s and UC (including associated symptoms such as abdominal pain or cramping, persistent diarrhea, diarrhea, frequent fevers and/or anemia), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
